Drug Profile
ADNF 9
Alternative Names: Activity-dependent neurotrophic factor 9Latest Information Update: 05 Dec 2007
Price :
$50
*
At a glance
- Originator Nonindustrial source; Yeda
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Unspecified
Most Recent Events
- 02 Jul 2001 No-Development-Reported for Unknown disease (Neuroprotection) in Israel (Unknown route)
- 02 Jul 2001 No-Development-Reported for Unknown disease (Neuroprotection) in USA (Unknown route)
- 05 Aug 1998 Preclinical development for Unknown disease (Neuroprotection) in Israel (Unknown route)